IRVINE, Calif., April 26, 2016 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint Neuro Navigation System will be utilized in two Practical Clinics at the Annual Meeting of the American Association of Neurological Surgeons (AANS) taking place on April 30 through May 4, 2016, in Chicago, Illinois. Both the lecture session and hands-on workshop will focus on advanced stereotactic techniques for implantation of electrodes and placement of laser ablation catheters for neurological procedures. Following the Practical Clinics, AANS attendees are invited to visit the MRI Interventions booth (#4804) to learn about ClearPoint Neuro Navigation and real-time MRI guided technologies enabling surgeons to perform a wide range of minimally-invasive neurosurgical procedures.
“We continue to see strong adoption of the ClearPoint Neuro Navigation System among leading functional neurosurgical centers due to the precision and accuracy provided by real-time MRI guidance and visualization," stated Frank Grillo, Chief Executive Officer for MRI Interventions. “Together with the 10-year safety data recently published in the Journal of Neurosurgery (JNS), we believe that the ClearPoint System offers a persuasive option for many neurosurgical procedures.”
The ClearPoint system allows surgeons to plan, target, and adjust trajectories under real time MRI-guided visualization for placement of electrodes, catheters and biopsy needles. The entire procedure takes place in an MRI suite and eliminates the need to attach a large, metal stereotactic headframe to an awake patient. Real time MRI imaging provides the surgeon with current views of the patient’s brain anatomy at the time of surgical planning, device alignment, and navigation of the device to target, resulting in improved accuracy and reduced risk of brain shift associated with standard imaging techniques.
About MRI Interventions, Inc.
Building on the imaging power of MRI, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. The ClearPoint System, which has received 510(k) clearance and is CE marked, utilizes a hospital’s existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com.
Statements herein concerning MRI Interventions, Inc. (the “Company”) plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. Uncertainties and risks may cause the Company's actual results to differ materially from those expressed in or implied by forward-looking statements. Particular uncertainties and risks include those relating to: the Company’s ability to obtain additional financing; estimates regarding the sufficiency of the Company’s cash resources; future revenues from sales of the Company’s ClearPoint system products; and the Company’s ability to market, commercialize and achieve broader market acceptance for the Company’s ClearPoint system products. More detailed information on these and additional factors that could affect the Company’s actual results are described in the “Risk Factors” section of the Company’s Form 10-K for the year ended December 31, 2015, which has been filed with the Securities and Exchange Commission.
Contact: Wendelin Maners, VP, Marketing MRI Interventions, Inc. 949-900-6833
Source:MRI Interventions, Inc.